Search results
Results from the WOW.Com Content Network
There are very few relative or absolute contraindications to the etonogestrel implant. Active hepatocellular carcinoma and a history of breast cancer more than 5 years prior to insertion are listed as relative contraindications. Active breast cancer is listed as an absolute contraindication. [2]
A 2013 meta-analysis concluded that every use of birth control pills is associated with a modest increase in the risk of breast cancer (relative risk 1.08) and a reduced risk of colorectal cancer (relative risk 0.86) and endometrial cancer (relative risk 0.57).
A lot of intimidating headlines have recently declared that taking hormonal birth control raises your risk of breast cancer. What you should know about birth control and breast cancer Skip to main ...
Combined hormonal contraception (CHC), or combined birth control, is a form of hormonal contraception which combines both an estrogen and a progestogen in varying formulations. [ 1 ] [ 2 ] The different types available include the pill , the patch and the vaginal ring , which are all widely available, [ 3 ] and an injection , which is available ...
The effects of hormonal birth control on breast cancer risk have been studied for decades. Many studies over the years have shown that hormone-containing birth control options, specifically ...
For premium support please call: 800-290-4726 more ways to reach us
Drospirenone is a progestin and antiandrogen medication which is used in birth control pills to prevent pregnancy and in menopausal hormone therapy, among other uses. [1] [10] It is available both alone under the brand name Slynd and in combination with an estrogen under the brand name Yasmin among others.
The side effects of cyproterone acetate (CPA), a steroidal antiandrogen and progestin, including its frequent and rare side effects, have been studied and characterized.It is generally well-tolerated and has a mild side-effect profile, regardless of dosage, when it used as a progestin or antiandrogen in combination with an estrogen such as ethinylestradiol or estradiol valerate in women.